Fundz
Back to SEC Filings
10-QHIGH RiskDETERIORATING

Twist Bioscience Corp

Filed: May 4, 2026 CIK: 0001581280
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

This 10-Q filing appears severely compromised with incomplete content extraction and data corruption. All three major sections contain identical, truncated forward-looking statements rather than proper section content, making comprehensive financial analysis impossible.

Red Flags Detected (5)

Complete absence of actual financial data and results of operations

No real Management Discussion & Analysis content despite 3,246 word count

Controls & Procedures section contains only forward-looking statements boilerplate

2 more red flags detected

Key Takeaways

Filing contains extensive forward-looking statements about AI/ML integration and international expansion

References to Express product portfolio and DNA synthesis platform capabilities

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateMay 4, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence15%
Red Flags5

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings